Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Cyclophosphamide news
All news on
Cyclophosphamide
(also known as
Cytoxan
): plants, production capacities, investments and involved companies.
17 June 2026
Genentech seeks FDA approval for Lunsumio VELO plus Polivy in relapsed/refractory LBCL
sBLA accepted for subcutaneous bispecific + ADC combo in relapsed/refractory large B‑cell lymphoma; FDA decision expected Feb 9, 2027.
Who will be producing Cyclophosphamide in the future?
Find out with
chemXplore Alpha
Learn more